Company intelligence / Profile preview

Reed & Carnrick

Jersey City, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

Reed & Carnrick was a historic American pharmaceutical company founded in 1860 by John Carnrick. The firm initially gained prominence for its development of infant formulas and digestive enzymes before evolving into a manufacturer of specialized prescription drugs. Its most recognized products included Kwell (lindane) for lice and scabies treatment, and Dilatrate-SR for the management of angina pectoris. The company was acquired by Block Drug in 1988, and its pharmaceutical assets were subsequently sold to Schwarz Pharma in 1995. Today, the legacy of Reed & Carnrick exists within the portfolios of larger global pharmaceutical entities like UCB and GSK.

Therapeutic areas: GastroenterologyCardiovascularDermatologyInfectious Diseases
Modalities: Small molecule
Industry: Pharma

Beyond the preview

Go deeper on Reed & Carnrick.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reed & Carnrick.

Explore the full profile